parkinson's and glp 1 GLP-1 Receptor Agonists: A New Treatment in Disease New studies on GLP-1 for

The findings dont necessarily suggest taking a GLP-1 will keep you from developing Alzheimers disease one day, but researchers did uncover some interesting elements that suggest these drugs may help, in certain groups, at least

Benefits of GLP-1 Microdosing Improved Tolerability Patients who discontinued GLP-1 medications due to side effects often find microdosing dramatically more tolerable enabling them to experience incretin benefits without the nausea that derailed their prior attempts

One patient was also seen to have solid food remnants with an esophagogastroduodenoscopy (EGD)

What You Need to Know About Flavonoids

In a double blinded placebo-controlled study, weekly injections of retatrutide (12 mg) in obese patients, in conjunction with lifestyle changes, showed average weight decreases of 22.1% over placebo patients after 48 weeks